Enterprise-wide Business Synergy and Profit Through Quality Metrics

Since the advent of the CGMPS in 1978, FDA-regulated companies responsible for the manufacture, preparation, distribution, or processing of human drugs, have utilized some degree of quality metrics for decision-making; moreover, recent manufacturing innovations coupled with advances in the lifecycle of the drug development and approval process unconditionally warrant the use of quality metrics to monitor quality control at critical milestones.

Download this white paper to discover:

• The current state of quality metrics (QM) within FDA-regulated industries and FDA's vision
• The use of QM as a cornerstone of strategic enterprise management
• The application of quality metrics throughout commercialization lifecycle in order to establish a quality culture